JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2024/74216.20277
Year : 2024 | Month : Nov | Volume : 18 | Issue : 11 Full Version Page : OC11 - OC15

Predictive Ability of Interstitial Fibrosis and Tubular Atrophy Scoring in Determining the Severity of Diabetic Kidney Disease: A Cross-sectional Study

Shamantha Gopichand1, Sunil Rajanna2, Tirthankar Mukherjee3, Rakshith Somanahalli Chikkanna4, Nalini Modepalli5

1 Assistant Professor, Department of Internal Medicine, BGS Global Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.
2 Professor, Department of Nephrology, Kempegowda Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.
3 Professor, Department of Internal Medicine, Kempegowda Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.
4 Assistant Professor, Department of Internal Medicine, Kempegowda Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.
5 Professor, Department of Pathology, Rajarajeshwari Institute of Medical Sciences, Bengaluru, Karnataka, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Rakshith Somanahalli Chikkanna, #412, Belli Kirana, 43rd Cross, 1st Main Road, Jayanagar 8th Block, Behind Apollo Tyres, Bengaluru-560070, Karnataka, India.
E-mail: drrakshithsc@gmail.com
Abstract

Introduction

Diabetic Kidney Disease (DKD) is a major complication of Diabetes Mellitus (DM). Renal biopsy is the gold standard for the diagnosis and management of many renal diseases. Renal Interstitial Fibrosis and Tubular Atrophy (IFTA), as well as the number of obsolescent glomeruli, are prognostic factors associated with Diabetic Nephropathy (DN).

Aim

To describe the renal biopsy profile of patients with DM presenting with renal disease and to determine the significance of IFTA scoring and the number of obsolescent glomeruli in predicting DKD and its severity.

Materials and Methods

This cross-divtional study was conducted over a period of three years, from 2019 to 2022, involving a total of 189 patients selected through purposive sampling. Patients with DM who presented with renal disease and required renal biopsy to confirm the diagnosis were admitted to the Department of General Medicine and Nephrology at Kempegowda Institute of Medical Sciences Hospital and Research Centre, Bengaluru, Karnataka, India. The biopsy reports were obtained and analysed. Data were analysed using Statistical Package for the Social Sciences (SPSS) version 20.0 and results were expressed using descriptive and inferential statistics. A p-value of <0.05 was considered statistically significant.

Results

The mean age of the participants was 53.02±11.00 years, with an age range from 21 to 81 years. Among the subjects, 78.3% were males and 21.7 were females. Based on the renal biopsy findings, DN was the most common condition, found in 127 subjects (67.6%). Nearly 50.0% of those with DN had Class IV chronic DN, followed by Class III (42.5%). Chronic interstitial nephritis was the most common Non Diabetic Kidney Disease (NDKD), accounting for 24.6% of cases. IFTA scoring was significantly associated with DKD and there was a significant positive correlation between the severity of IFTA scores and the number of obsolescent glomeruli with the class of DKD. A unit rise in the IFTA score and the number of obsolescent glomeruli increased the risk of having severe DKD (Class III and Class IV) by 4.32 times and 1.24 times, respectively, compared to those with less severe forms (Class I and II) (p<0.05).

Conclusion

The IFTA scoring and the number of obsolescent glomeruli were found to be significant independent predictors of the severity of DKD.

Keywords

Diabetic glomerulosclerosis,Intracapillary glomerulosclerosis,Kimmelstiel-Wilson disease,Nephropathy,Nodular glomerulosclerosis

Introduction

Diabetes mellitus is one of the fastest-growing health challenges of the 21st century. The International Diabetes Federation has estimated that around 537 million people were living with diabetes in 2021, with an expected increase to 783 million by the year 2045 [1]. Diabetic Nephropathy (DN) has been identified as one of the most significant long-term complications of diabetes, leading to End-stage Renal Disease (ESRD) worldwide [2]. More than 40% of people with diabetes are estimated to develop Chronic Kidney Disease (CKD), including those who may progress to ESRD, requiring renal replacement therapies in the form of either dialysis or transplantation [3].

Patients with diabetes and CKD have an increased risk of all-cause mortality, cardiovascular mortality and kidney failure. The natural course of DKD progression includes glomerular hyperfiltration, followed by progressive albuminuria, declining Glomerular Filtration Rate (GFR) and ultimately ESRD. Findings of glomerular hypertrophy, glomerulosclerosis and tubulointerstitial inflammation and fibrosis are associated with the metabolic changes in diabetes. The risk of onset and progression of DKD persists despite current diabetes therapies. Therefore, there is an urgent need to improve health outcomes for patients with DKD. To achieve this, it is crucial to identify the disease at an early stage and develop therapeutic agents targeting kidney-specific disease mechanisms, such as glomerular hyperfiltration, inflammation and fibrosis [4].

The clinical factors influencing the prediction of the progression of CKD to ESRD in DN include the duration of diabetes, blood pressure, estimated Glomerular Filtration Rate (eGFR), proteinuria and glycated haemoglobin a1c level [5]. However, DN affects all structural components of the kidney and manifests with diverse pathological findings. Therefore, recognising such lesions and their morphological characteristics via renal biopsy may help in preventing, slowing down, or even reversing the processes of DN [6].

In diabetic patients, the results of renal biopsy can be classified into DN, Non Diabetic Renal Disease (NDRD), or DN with NDRD (mixed forms). Renal biopsy in DN, especially in patients undergoing new treatments, may play a role in assessing renal protection or regression of diabetic histological lesions. Additionally, it has been observed that early diagnosis and subsequent treatment of NDRD in diabetic patients have led to better prognosis [7].

To aid DN patients, it is important to identify prognostic factors. The Renal Pathological Society has indicated that Glomerular Basement Membrane (GBM) thickening, mesangial expansion, nodular sclerosis and advanced diabetic glomerulosclerosis are key features. A score is calculated based on tubulointerstitial and vascular lesions, which include IFTA, Arteriolar Hyalinosis (AH), inflammatory interstitial infiltrates, the presence of large vessels and arteriosclerosis [8]. Furthermore, renal IFTA is one of the primary endpoints of kidney injury and its accurate quantification in biopsy samples aids in establishing the diagnosis and assessing the severity of the disease [9]. The severity of IFTA has been noted to be associated with renal events and mortality in patients with type 2 diabetes and biopsy-proven DN [10]. Additionally, obsolescent glomerulosclerosis is recognised as another prognostic factor in DN, as highlighted in previous literature [11].

Data on renal biopsy, particularly in the current study setting, is very limited. The present study contributes to the existing literature by addressing the gap regarding the magnitude of these findings and by providing data on pathological markers such as IFTA and obsolescent glomerulosclerosis [5,12]. Therefore, the present study was conducted to describe the renal biopsy profiles among the subjects and to determine the significance of the number of obsolescent glomeruli and IFTA scoring in predicting DKD and its severity.

Materials and Methods

The present study was a cross-sectional study conducted over a period of three years at an urban tertiary care hospital in the Department of General Medicine and Nephrology at Kempegowda Institute of Medical Sciences Hospital and Research Centre, Bengaluru, Karnataka, India, from 2019 to 2022, involving a total of 189 patients selected through purposive sampling. Ethical clearance was obtained from the Institutional Ethics Committee (KIMS/IEC/A150/M/2024).

Inclusion and Exclusion criteria: The study included patients with diabetes mellitus who presented with renal disease and required a renal biopsy to confirm the diagnosis. These patients were admitted to the study Institute. Patients who were unwilling to participate in the study were excluded.

Sample size calculation: Considering 34.4% prevalence of CKD stage 3 among type 2 diabetic patients in India [13] and an additional 7% for inadequate sampling, the sample size of 189 was estimated with 5% alpha error, 7% absolute precision by applying the formula n= zα/2 2 pq/l2 where n- sample size, p-prevalence of DKD, q=1-p, l-precision (or margin of error), zα/2- 1.96 for alpha 0.05.

Study Procedure

After obtaining written informed consent from all the study participants, details regarding the socio-demographic data and clinical history were collected using a semi-structured questionnaire by interview technique. Clinical examination included vitals, general physical examination and systemic examination were done.

A renal biopsy was performed under real-time ultrasonography guidance by nephrologists. The indications for the renal biopsy included proteinuria of more than 0.5 g/day or atypical DN, such as renal involvement without diabetic retinopathy and/or the presence of urinary Red Blood Cells (RBCs). Renal tissue was obtained through needle biopsy and specimens were processed for light microscopy, immunofluorescence and Electron Microscopy (EM). A biopsy core was labelled as an adequate sample if it contained five glomeruli for glomerular lesions and ten glomeruli in cases of tubulointerstitial disease. Biopsy samples with an inadequate number of glomeruli for either light microscopy or immunofluorescence studies were excluded from the analysis. Transplant kidney biopsies were also excluded from the study. The biopsy report was obtained and analysed for the profile [14]. The severity of lesions was graded into four classes and IFTA scores were noted, along with the number of glomeruli and obsolescent glomeruli [15].

Operational Definition

Classes of Diabetic Nephropathy (DN): Based on the glomerular involvement, the severity of lesions is graded into four classes. Class I is characterised by normal optical microscopy and basal glomerular thickening observed in EM. Class II is characterised by mesangial expansion and is subdivided into Class IIa and Class IIb according to the severity of this lesion. Class III is characterised by the presence of at least one nodular lesion (Kimmelstiel-Wilson lesion), provided that no more than 50% of the glomeruli are sclerosed. Class IV, or advanced diabetic glomerulosclerosis, designates biopsies with more than 50% glomerulosclerosis when this lesion can be attributed to DN, specifically the presence of Class II or III lesions, or a long history of diabetes along with diabetic retinopathy [6].

Pure Non Diabetic Kidney Disease (NDKD): This was defined by the presence of predominant vasculopathy, interstitial fibrosis, tubular atrophy and/or specific glomerular changes in the absence of classical changes associated with DKD [12].

Interstitial Fibrosis and Tubular Atrophy (IFTA) scores: These scores are evaluated using a semi-quantitative scale of 0-3+, reflecting the percentage of the total involved area of interstitium and tubules as follows: 0 for absence of interstitial fibrosis, 1 for <25%, 2 for 25%-50% and 3 for >50% [15].

Obsolescent glomerulosclerosis is characterised by ischaemic obsolescent glomerulosclerosis, which presents as a retracted glomerular tuft surrounded by a hypocellular homogeneous collagen matrix beginning at the vascular pole adjacent to the glomerular stalk [11].

The terms DN, DKD, NDRD and NDKD are used interchangeably in the current study.

Statistical Analysis

The data were entered into Microsoft Excel and analysed using SPSS version 20.0. Categorical data were presented as proportions, while continuous data were expressed as mean±SD or median with range, depending on whether the data followed a parametric or non parametric distribution. Categorical variables were analysed using the Chi-square test and continuous non parametric variables were compared between groups using the Mann-Whitney U test. The strength of association was expressed using odds ratios, calculated through bivariate logistic regression. The correlation between ordinal data, specifically severity of DKD, IFTA scores and the number of obsolescent glomeruli was analysed using Spearman’s correlation coefficient. A p-value of less than 0.05 was considered statistically significant.

Results

A total of 189 study subjects were included in the analysis. The majority, 114 (60.3%), were aged between 41 to 60 years, with a mean age of 53.02±11.00 years, ranging from 21 to 81 years. Among the participants, 148 (78.3%) were males. Based on the renal biopsy findings, DN was the most common diagnosis, found in 127 (67.6%) subjects, while the remaining 61 (32.4%) had NDKD [Table/Fig-1].

Distribution of study subjects based on socio-demographic and clinical details.

VariablesFrequency (n)Percentage (%)
Age-group in years (N=189)
≤4002412.7
41-6011460.3
>6005127.0
Mean age±SD (years)53.02±11.00
Sex (n=189)
Males14878.3
Females04121.7
Renal biopsies (n=188)¥
Diabetic Nephropathy (DN)12767.6
Non Diabetic Kidney Disease (NDKD)06132.4

¥One has been excluded as it had inadequate sample


Among those with DN, 63 (49.6%) had Class IV chronic DN, followed by Class III in 54 (42.5%) cases, Class IIb in 6 (4.7%), Class IIa in 2 (1.6%) and Class I in 2 (1.6%) [Table/Fig-2].

Distribution of study subjects based on histopathological findings in Diabetic Nephropathy (DN).

Histopathological findings in diabetic nephropathy (DN) (n=127)Frequency (n)Percentage (%)
Class I021.6
Class IIa021.6
Class IIb064.7
Class III5442.5
Class IV6349.6

Of those with NDKD, chronic interstitial nephritis was the most common diagnosis, found in 15 (24.6%) subjects, followed by acute tubular injury and membranous glomerulonephritis, each present in 7 (11.5%) subjects. Chronic glomerulosclerosis and focal segmental glomerulosclerosis were found in 6 (9.8%) subjects each [Table/Fig-3].

Distribution of study subjects based on histopathological findings in Non Diabetic Kidney Disease (NDKD).

Histopathological findings in Non Diabetic Kidney Disease (NDKD) (n=61)Frequency (n)Percentage (%)
Chronic interstitial nephritis1524.6
Acute tubular injury0711.5
Membranous glomerulonephritis0711.5
Chronic glomerulosclerosis069.8
Focal segmental glomerulosclerosis069.8
Immunoglobulin A (IgA) nephropathy058.2
Acute interstitial nephritis046.6
Minimal change disease034.9
Acute tubular interstitial nephritis034.9
Membranoproliferative glomerulonephritis034.9
Cast nephropathy023.3
Pyelonephritis023.3
Acute on chronic interstitial nephritis023.3
Hypertensive nephrosclerosis023.3
Chronic glomerulonephritis011.6
Mesangial proliferative glomerulonephritis011.6
C3 glomerulonephritis011.6
Hyperfiltration injury011.6

n>61 and % >100 because multiple co-existing findings


The proportion of subjects with DKD increased with rising IFTA scores, from 11 (20.4%) to 51 (91.1%). However, the proportions of individuals with IFTA scores of 2 and 3 remained nearly equal. Notably, IFTA scoring was significantly associated with DKD compared to NDKD (p<0.005) [Table/Fig-4].

Distribution of study subjects based on IFTA scoring among Diabetic (DKD) and Non Diabetic Kidney Disease (NDKD).

IFTA scoringDiabetic Kidney Disease (DKD)Non Diabetic Kidney Disease (NDKD)χ2-value(p-value)
011 (20.4)43 (79.6)77.91 (<0.005)*
147 (82.5)10 (17.5)
251 (91.1)05 (8.9)
318 (85.7)03 (14.3)

*indicates statistically significant association at p<0.05


The median number of obsolescent glomeruli (6 vs 2) and IFTA scores (2 vs 0) were significantly higher in chronic DN compared to NDKD (p<0.001). However, the number of glomeruli did not differ significantly between the two groups (p=0.38) [Table/Fig-5].

Comparison of IFTA scores in Chronic Diabetic Nephropathy (DN) and Non Diabetic Kidney Disease (NDKD).

VariablesMedian (Range)Mann-Whitney U value (p-value)
DNNDKD
No. of glomeruli14 (1 to 55)15 (1 to 64)3565.5(0.38)
No. of obsolescent glomeruli06 (0 to 45)02 (0 to 34)2522.5(<0.001)*
IFTA scores02 (0 to 3)00 (0 to 3)1353.0(<0.001)*

*indicates statistically significant difference at p<0.05


There was a significant correlation between the severity of DKD and IFTA scores, indicating that IFTA scores significantly increase with the severity of DKD (r=0.7; p<0.001), where the r value indicates a high positive correlation [Table/Fig-6]. Similarly, significant positive correlations were established between the number of obsolescent glomeruli and the severity of DKD (r=0.7; p<0.05) [Table/Fig-7].

Correlation between severity of Diabetic Kidney Disease (DKD) and IFTA Scores.

*indicates significant statistical correlation at p<0.05

Correlation between severity of Diabetic Kidney Disease (DKD) and number of obsolescent glomeruli.

*indicates significant statistical correlation at p<0.05

Among the DN patients, the median IFTA scores and the median number of obsolescent glomeruli in those with severe DKD (Class III and Class IV) were 2 and 7, respectively, while in those with Class I and II, they were 1 and 1.5, respectively. These differences were statistically significant (p=0.003). The odds ratio of 4.32 suggests that for each unit increase in the IFTA score, there was a 4.32-fold higher risk of having severe DKD (Class III and Class IV) compared to those with less severe forms (Class I and II). Similarly, a unit increase in the number of obsolescent glomeruli increased the risk of having severe DKD (Class III and Class IV) by 1.24 times compared to those with less severe forms (Class I and II), respectively (p=0.003) [Table/Fig-8].

Predictive ability of IFTA scores and number of obsolescent glomeruli in severity of Chronic Diabetic Nephropathy (DN).

Predictive variablesMedian (Range)Mann-Whitney U value (p-value)OR (95% CI)
Class I/IIClass III/IV
IFTA scores01 (0 to 2)02 (0 to 3)277.00 (0.003)*4.32* (1.60 to 11.63)
Number of obsolescent glomeruli1.5 (0 to 16)07 (0 to 45)268.50 (0.003)*1.24 (1.02 to 1.52)

*indicates statistical significance at p<0.05


Discussion

In the current study, nearly two-thirds of diabetics had DN and most of the subjects with DN had Class IV and Class III chronic DN. The number of obsolescent glomeruli and IFTA scores were found to be independent predictors of the severity of DN.

India is one of the three countries with the highest burden of CKD due to DM [16]. Although renal involvement in diabetes is primarily due to DN, a considerable proportion of patients undergoing kidney biopsy have been noted to exhibit NDKD, which can present alone or superimposed on DKD [4,17,18]. Given the high burden of diabetes in India, both DKD and NDKD are expected to be prevalent [12]. There are significant therapeutic and prognostic implications in diagnosing NDKD in diabetic patients [17].

Previously conducted research has reported severe glomerular injury, an increased degree of interstitial inflammation, severe IFTA and a higher occurrence of arterial hypertension and arteriosclerosis, all of which are associated with renal endpoints indicating renal damage [19,20]. The critical role of these factors in the progression of DN has also been established in other studies [20]. Similarly, the occurrence of IFTA has also been noted in NDKD [12]. Obsolescent glomeruli appeared to be significantly associated with end-stage renal disease in patients with type 2 diabetes but did not retain its significance after adjusting for confounders [11].

In addition to this background, data on renal biopsy findings and the pathological features that have prognostic utility in DN are limited [5,12]. Hence, this study was conducted to assess the histopathological features of patients who underwent renal biopsy [18] and to determine the association of IFTA scores with DKD and its severity.

Tong X et al., reported the prevalence rate of DN in different studies ranging from 8.2% to 62.7%, with an average of 41.3%. Similarly, DN was the most common diagnosis found in 67.6% of the study participants [21]. Prakash J et al., reported the mean age of study subjects to be around 52 years, with the majority being male. In their study, isolated DN was found in 52% of cases and DN with superimposed NDKD was present in 20%. The present study found a mean age of around 53 years, with the majority being male and 67.6% of participants had DN [22].

Sahay M et al., noted that the most common histological class was Class IV, observed in 43.02% of cases, followed by Class III DN in 27.90% of cases. Class IIa and Class IIb were each found in 12.79% of cases, while Class I DN was present in 3.48% of cases [23]. Zajjari Y et al., found Class III to be the most common histological class among DN cases, accounting for 42.3% [24]. However, the present study findings were consistent with those of Sahay M et al., showing that nearly 50.0% had Class IV chronic DN, followed by Class III (42.5%), Class IIb (4.7%), Class IIa (1.6%) and Class I (1.6%) [23]. The current findings slightly differed from those of Zajjari Y et al., as the severity of DN manifestations depends on the chronicity of diabetes and glycemic control [24,25].

Tolani P et al., found NDKD in 48.15% of cases, with IgA nephropathy being the most common, followed by membranous glomerulopathy, focal segmental glomerulosclerosis and other conditions such as tubulointerstitial diseases and crescentic glomerulonephritis [14]. In contrast, this study observed NDKD in 32.4% of cases, with chronic interstitial nephritis being the most prevalent, followed by acute tubular injury, membranous glomerulonephritis, chronic glomerulosclerosis, focal segmental glomerulosclerosis and IgA nephropathy. Acute interstitial nephritis and other diseases such as minimal change disease, acute tubular interstitial nephritis, membranoproliferative glomerulonephritis, cast nephropathy, pyelonephritis, acute on chronic interstitial nephritis, hypertensive nephrosclerosis, chronic glomerulonephritis, mesangial proliferative glomerulonephritis and C3 glomerulonephritis accounted for less than 5% of cases. The differences in the types of NDKD may be attributed to varying study settings and the duration of diabetes [14].

Zajjari Y et al., did not show any significant difference in the number of glomeruli across different classes of DN, with means of 14 and 15, indicating optimal quality of the biopsy samples [24]. As explained above, a study by Zhao L et al., found that obsolescent glomeruli were significantly associated with end-stage renal disease in patients with type 2 diabetes; however, this significance did not hold after adjusting for confounders [11]. These findings align with the current study, although the loss of significance and the observed differences may be attributed to variations in the study settings. Zhao L et al., also reported a 1.24 times higher risk of having Class III and IV DN compared to those with Class I and II DN.

As IFTA scores increased, the proportion of subjects with DKD rose until IFTA score 2, after which the proportion remained relatively stable, with a slight decrease noted at IFTA score 3. The scores were significantly associated with DKD and IFTA scores (2 vs. 0) were significantly higher in chronic DN compared to NDKD in this study. A significant positive correlation between IFTA scores and the grade of DN was also observed in the current study, consistent with findings from other studies conducted by Kim T et al., Shimizu M et al., and Zajjari Y et al., which demonstrated associations and positive correlations with CKD stage, as well as higher mean values in Class IV DN [8,10,24]. Additionally, this study highlighted the increased risk of higher severity with rising IFTA scores, showing a 4.32 times higher risk of having severe DKD (Class III and Class IV) compared to those with less severe forms (Class I and II).

Limitation(s)

The study was limited to a single setting and purposive sampling was used due to logistical constraints and the nature of the investigation.

Conclusion(s)

The data indicate that DN contributed to nearly two-thirds of the individuals with diabetes, while one-third had NDKD. More than 90% of those with DN had Class IV and Class III chronic DN. Among those with NDKD, nearly 50% exhibited pathological findings of chronic interstitial nephritis, acute tubular injury and membranous glomerulonephritis. Additionally, more than 30% of individuals with NDKD presented with chronic glomerulosclerosis, focal segmental glomerulosclerosis, IgA nephropathy and acute interstitial nephritis. The number of obsolescent glomeruli and IFTA scores showed a significant association with DN. These factors were also found to be independent predictors of the severity of DN, indirectly indicating their prognostic significance in this condition. Conducting similar studies in different settings or using a case-control study design, while adjusting for confounders such as the duration of diabetes and other associated co-morbidities, might help to generalise the findings of the current study.

¥One has been excluded as it had inadequate samplen>61 and % >100 because multiple co-existing findings*indicates statistically significant association at p<0.05*indicates statistically significant difference at p<0.05*indicates statistical significance at p<0.05

Author Declaration:

    Financial or Other Competing Interests: None

    Was Ethics Committee Approval obtained for this study? Yes

    Was informed consent obtained from the subjects involved in the study? Yes

    For any images presented appropriate consent has been obtained from the subjects. NA

Plagiarism Checking Methods: [Jain H et al.]

    Plagiarism X-checker: Jul 16, 2024

    Manual Googling: Aug 03, 2024

    iThenticate Software: Sep 20, 2024 (17%)

ETYMOLOGY:

Author Origin

Emendations:

6

References

[1]International Diabetes Federation IDF Diabetes Atlas-Diabetes around the world in 2021 [Internet] 2021 10th ednBrussels, BelgiumInternational Diabetes FederationAvailable from: https://www.diabetesatlas.org  [Google Scholar]

[2]Ritz E, Zeng XX, Rychlík I, Clinical manifestation and natural history of diabetic nephropathy Contrib Nephrol 2011 170:19-27.10.1159/00032493921659754  [Google Scholar]  [CrossRef]  [PubMed]

[3]American Diabetes AssociationStandards of medical care in diabetes--2014 Diabetes Care 2014 37(Suppl 1):S14-80.10.2337/dc14-S01424357209  [Google Scholar]  [CrossRef]  [PubMed]

[4]Alicic RZ, Rooney MT, Tuttle KR, Diabetic kidney disease: Challenges, progress, and possibilities Clin J Am Soc Nephrol 2017 12(12):2032-45.10.2215/CJN.1149111628522654  [Google Scholar]  [CrossRef]  [PubMed]

[5]Stefan G, Stancu S, Zugravu A, Petre N, Mandache E, Mircescu G, Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification Medicine 2019 98(27):e1633310.1097/MD.000000000001633331277183  [Google Scholar]  [CrossRef]  [PubMed]

[6]Qi C, Mao X, Zhang Z, Wu H, Classification and differential diagnosis of diabetic nephropathy Journal of Diabetes Research 2017 2017:863713810.1155/2017/863713828316995  [Google Scholar]  [CrossRef]  [PubMed]

[7]Bermejo S, Pascual J, Soler MJ, The current role of renal biopsy in diabetic patients Minerva Medica 2017 109(2):116-25.10.23736/S0026-4806.17.05446-529115800  [Google Scholar]  [CrossRef]  [PubMed]

[8]Kim T, Kwak Y, Lee JY, Shin H, Kim JS, Yang JW, Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy Kidney Res Clin Pract 2022 41(5):545-55.10.23876/j.krcp.22.12336239058  [Google Scholar]  [CrossRef]  [PubMed]

[9]Edelstein CL, Biomarkers of kidney disease 2016 Academic Press  [Google Scholar]

[10]Shimizu M, Furuichi K, Kitajima S, Toyama T, Oshima M, Ogura H, Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy BMC Nephrology 2021 22:01-02.10.1186/s12882-021-02510-y34560842  [Google Scholar]  [CrossRef]  [PubMed]

[11]Zhao L, Liu F, Li L, Zhang J, Wang T, Zhang R, Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes Scientific Reports 2021 11(1):01-04.10.1038/s41598-021-83856-z33633132  [Google Scholar]  [CrossRef]  [PubMed]

[12]Prasad N, Veeranki V, Bhadauria D, Kushwaha R, Meyyappan J, Kaul A, Non-Diabetic Kidney Disease in Type 2 Diabetes Mellitus: A changing spectrum with therapeutic ascendancy Journal of Clinical Medicine 2023 12(4):170510.3390/jcm1204170536836240  [Google Scholar]  [CrossRef]  [PubMed]

[13]Hussain S, Habib A, Najmi AK, Limited knowledge of chronic kidney disease among type 2 diabetes mellitus patients in India Int J Environ Res Publ Health 2019 16(8):144310.3390/ijerph1608144331018581  [Google Scholar]  [CrossRef]  [PubMed]

[14]Tolani P, Pasari AS, Bhawane A, Balwani MR, Renal biopsy profile of diabetic patients: A single-center study J Nephrol Soc 2022 1(1):30-32.10.4103/jtns.jtns_7_22  [Google Scholar]  [CrossRef]

[15]Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Serón D, Renal biopsy in type 2 diabetic patients Journal of Clinical Medicine 2015 4(5):998-1009.10.3390/jcm405099826239461  [Google Scholar]  [CrossRef]  [PubMed]

[16]Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, Global, regional, and national burden of diabetes-related chronic kidney disease from 1990 to 2019 Frontiers in Endocrinology 2021 12:67235010.3389/fendo.2021.67235034276558  [Google Scholar]  [CrossRef]  [PubMed]

[17]John EE, Roy S, Eapen JJ, Alam R, Varughese S, When to suspect non-diabetic kidney disease in a diabetic patient? Cureus 2022 14(8):e2809110.7759/cureus.28091  [Google Scholar]  [CrossRef]

[18]Erdogmus S, Kiremitci S, Celebi ZK, Akturk S, Duman N, Ates K, Non-diabetic kidney disease in type 2 diabetic patients: Prevalence, clinical predictors and outcomes Kidney and Blood Pressure Research 2018 42(5):886-93.10.1159/00048453829130997  [Google Scholar]  [CrossRef]  [PubMed]

[19]Zhu X, Xiong X, Yuan S, Xiao L, Fu X, Yang Y, Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China Journal of Diabetes and its Complications 2016 30(3):537-41.10.1016/j.jdiacomp.2015.12.00226796433  [Google Scholar]  [CrossRef]  [PubMed]

[20]Zhou T, Wang Y, Shen L, Li X, Jiao Q, Li Z, Clinical and histological predictors of renal survival in patients with biopsy-proven diabetic nephropathy Kidney Diseases 2022 8(1):93-102.10.1159/00051822235224010  [Google Scholar]  [CrossRef]  [PubMed]

[21]Tong X, Yu Q, Ankawi G, Pang B, Yang B, Yang H, Insights into the role of renal biopsy in patients with T2DM: A literature review of global renal biopsy results Diabetes Therapy 2020 11:1983-99.10.1007/s13300-020-00888-w32757123  [Google Scholar]  [CrossRef]  [PubMed]

[22]Prakash J, Patel PS, Iqbal M, Sharma SS, Singh S, Agrawal NK, Histological spectrum of clinical kidney disease in type 2 diabetes mellitus patients with special reference to non-albuminuric diabetic nephropathy: A kidney biopsy-based study J Assoc Physicians India 2022 70(8):37-40.10.5005/japi-11001-006036082725  [Google Scholar]  [CrossRef]  [PubMed]

[23]Sahay M, Mahankali RK, Ismal K, Vali PS, Sahay RK, Swarnalata G, Renal histology in diabetic nephropathy: A novel perspective Indian J Nephrol 2014 24(4):22610.4103/0971-4065.13299925097335  [Google Scholar]  [CrossRef]  [PubMed]

[24]Zajjari Y, Aatif T, Hassani K, Benbria S, El Kabbaj D, Renal histology in diabetic patients Saudi J Med Med Sci 2019 7(1):2210.4103/sjmms.sjmms_76_1830787853  [Google Scholar]  [CrossRef]  [PubMed]

[25]Samsu N, Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment BioMed Research International 2021 2021:149744910.1155/2021/149744934307650  [Google Scholar]  [CrossRef]  [PubMed]